International Business Machines Corp vs Nuwellis Inc — how do they compare? International Business Machines Corp trades at $237.32 (market cap $224.62B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: International Business Machines Corp is far larger — about 413817.2× Nuwellis Inc's market cap, and International Business Machines Corp pays a 2.84% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| IBM | NUWE | |
|---|---|---|
Market Cap | $224.62B | $542.80K |
Volume | 4,481,527 | — |
Sector | Technology | Technology |
52-Week High | $329.23 | $220.50 |
52-Week Low | $205.77 | $1.42 |
Enterprise Value | $281.76B | -$1.27M |
Dividend Yield | 2.84% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →